Michelle L. Griffith, M.D.

Assistant Professor

michelle.l.griffith.1@vanderbilt.edu
Faculty Appointments
Assistant Professor of Medicine
Education
M.D., Medicine, Vanderbilt University, Nashville, TennesseeB.S., Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania
Clinical Description
Clinical interests include type 1 and type 2 diabetes and thyroid disease, as well as new models of care delivery including telemedicine.
Clinical Research Keywords
diabetes telemedicine telehealth
Publications
Griffith ML, Siminerio L, Payne T, Krall J. A Shared Decision-Making Approach to Telemedicine: Engaging Rural Patients in Glycemic Management. J Clin Med. 2016 Nov 11/17/2016; 5(11): PMID: 27869655, PMCID: PMC5126800, PII: jcm5110103, DOI: 10.3390/jcm5110103, ISSN: 2077-0383.

Fuji S, Rovó A, Ohashi K, Griffith M, Einsele H, Kapp M, Mohty M, Majhail NS, Engelhardt BG, Tichelli A, Savani BN. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT. Bone Marrow Transplant [print-electronic]. 2016 Aug; 51(8): 1041-9. PMID: 27042848, PII: bmt201681, DOI: 10.1038/bmt.2016.81, ISSN: 1476-5365.

Griffith ML, Boord JB, Eden SK, Matheny ME. Clinical inertia of discharge planning among patients with poorly controlled diabetes mellitus. J. Clin. Endocrinol. Metab [print-electronic]. 2012 Jun; 97(6): 2019-26. PMID: 22466346, PII: jc.2011-3216, DOI: 10.1210/jc.2011-3216, ISSN: 1945-7197.

Engelhardt BG, Jagasia SM, Crowe JE, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood [print-electronic]. 2012 Mar 3/8/2012; 119(10): 2417-21. PMID: 22262764, PMCID: PMC3311262, PII: blood-2011-10-384750, DOI: 10.1182/blood-2011-10-384750, ISSN: 1528-0020.

Matheny ME, Fitzhenry F, Speroff T, Green JK, Griffith ML, Vasilevskis EE, Fielstein EM, Elkin PL, Brown SH. Detection of infectious symptoms from VA emergency department and primary care clinical documentation. Int J Med Inform [print-electronic]. 2012 Mar; 81(3): 143-56. PMID: 22244191, PII: S1386-5056(11)00238-3, DOI: 10.1016/j.ijmedinf.2011.11.005, ISSN: 1872-8243.

Savani BN, Griffith ML, Jagasia S, Lee SJ. How I treat late effects in adults after allogeneic stem cell transplantation. Blood [print-electronic]. 2011 Mar 3/17/2011; 117(11): 3002-9. PMID: 21193694, PMCID: PMC3062306, PII: blood-2010-10-263095, DOI: 10.1182/blood-2010-10-263095, ISSN: 1528-0020.

Griffith ML, Jagasia MH, Misfeldt AA, Chen H, Engelhardt BG, Kassim A, Savani BN, Survant M, Jagasia SM. Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2011 Jan; 17(1): 86-92. PMID: 20561594, PII: S1083-8791(10)00254-5, DOI: 10.1016/j.bbmt.2010.06.010, ISSN: 1523-6536.

Griffith ML, Savani BN, Boord JB. Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management. Blood [print-electronic]. 2010 Aug 8/26/2010; 116(8): 1197-204. PMID: 20439623, PII: blood-2010-03-276576, DOI: 10.1182/blood-2010-03-276576, ISSN: 1528-0020.

Griffith ML, Jagasia M, Jagasia SM. Diabetes mellitus after hematopoietic stem cell transplantation. Endocr Pract. 2010 Jul; 16(4): 699-706. PMID: 20439241, PII: T44Q154K44003813, DOI: 10.4158/EP10027.RA, ISSN: 1934-2403.

Briscoe VJ, Griffith ML, Davis SN. The role of glimepiride in the treatment of type 2 diabetes mellitus. Expert Opin Drug Metab Toxicol. 2010 Feb; 6(2): 225-35. PMID: 20055691, DOI: 10.1517/17425250903512955, ISSN: 1744-7607.

Csink AK, Bounoutas A, Griffith ML, Sabl JF, Sage BT. Differential gene silencing by trans-heterochromatin in Drosophila melanogaster. Genetics. 2002 Jan; 160(1): 257-69. PMID: 11805061, PMCID: PMC1461954, ISSN: 0016-6731.